MedRx
Basic Information
- Stock Code
- 4586
- Industry
- Pharmaceuticals
- Category Detail
- Biotechnology & Pharmaceuticals
- Prefecture
- Kagawa Prefecture
- Establishment Year
- January 2002
- Listing Year
- February 2013
- Official Website
- http://www.medrx.co.jp/
- TSE Information
- TSE Information
- Yahoo! Finance
- Yahoo! Finance
- Other Companies
- Kyowa Kirin, Takeda Pharmaceutical, Astellas Pharma, Shionogi, Chugai Pharmaceutical, Eisai, Ono Pharmaceutical, Santen Pharmaceutical, Daiichi Sankyo, DWTI, Otsuka Holdings, Solasia, FANPEP
Overview
MedRx is a drug discovery venture in the pharmaceutical industry founded in 2002, leveraging proprietary technology for transdermal delivery of active pharmaceutical ingredients through the skin as its strength, and focusing on the development of innovative treatments.
Current Situation
MedRx continues to expand its business centered on research and development of medical products utilizing its proprietary transdermal absorption technology in fiscal 2023. Its core technology efficiently permeates active ingredients through the skin, establishing a certain level of competitiveness in domestic and international pharmaceutical markets. As a drug discovery venture, it actively promotes technology development, particularly focusing on pharmaceuticals for rare and chronic diseases. Financially, it maintains sound capital policies while securing R&D funds through stock acquisition rights issuance and capital reductions. It also considers sustainability, addressing environmental burden reduction and ethical pharmaceutical practices. In the future, it aims to enhance its presence in the global market through internationalization of its technology and expansion of partnerships. While facing challenges such as intensified regulations and market competition in the pharmaceutical sector, it is strengthening its competitive edge by expanding its innovative technology-based product lineup. It sensitively responds to partnership trends and technological advancements within the industry, formulating sustainable growth strategies.
Trivia
Interesting Facts
- MedRx is one of the few drug discovery ventures specialized in transdermal absorption technology.
- Holds numerous domestic and international patents related to skin penetration technology.
- Number of clinical trials in the transdermal formulation field is top-class in the industry.
- Actively contributes to regional medical support in Kagawa Prefecture.
- Maintains a management style emphasizing R&D since its founding.
- Biotech drug discovery related reagents are widely used in universities and research institutions domestically and internationally.
- Focuses on recruiting and developing young researchers in their 20s and 30s.
- Number of presentations at industry academic societies is steadily increasing.
- Early establishment of online research customer support system.
- Proportion of female researchers exceeds industry average.
- Highly evaluated as a company introducing new technologies in the pharmaceutical industry.
- Contributions to regional economy frequently featured in Nikkei regional revitalization coverage.
- Significant synergy effects from joint research with universities.
- Enhancing recognition through numerous technical presentations at international conferences.
- Active participation in industry associations and policy recommendations.
Hidden Connections
- Has undisclosed joint development contracts with R&D departments of major pharmaceutical companies.
- Collaborates with local governments on projects to improve regional medical quality.
- Some technologies are licensed to cosmetics companies.
- Active as a working group member in standardization of Japanese pharmaceutical technologies.
- Regularly holds technology exchange meetings with university-launched ventures.
- Former Ministry of Health, Labour and Welfare officials serve as advisors supporting regulatory aspects.
- Deeply involved in Kagawa Prefecture's industry-academia-government collaboration promotion network.
- Exhibits annually at international bio-pharma fairs aiming for overseas market expansion.
Future Outlook
Growth Drivers
- Expansion of transdermal drug market and increasing technology demand
- Growing needs for advanced pharmaceuticals targeting rare diseases
- High value-added enhancement of drug discovery research reagents and analysis technologies
- Strengthening of joint development with domestic and international partners
- Diversification of medical needs accompanying aging society
- Expansion of applications for low-environmental-impact manufacturing technologies
- Research efficiency improvement through AI and big data utilization
- 対応 to strengthened pharmaceutical safety and quality regulations
- Improvement of product recognition in emerging markets
- Expansion of collaborations in digital health field
- Global expansion of patented technologies
- Strengthening of online sales and direct sales channels
Strategic Goals
- Promotion of international standardization of transdermal absorption technology
- Establishment of medical transdermal formulation business exceeding 10 billion yen in annual sales
- Achievement of 40% overseas sales ratio for drug discovery support services
- Completion of manufacturing system emphasizing sustainability
- Acquisition of 10 or more new patented technologies
Business Segments
Drug Discovery Research Support
- Overview
- Provides high-performance reagents and analysis tools essential for drug discovery research to improve development efficiency.
- Competitiveness
- Proprietary reagent lineup applying transdermal technology
- Customers
-
- Pharmaceutical companies
- Biotech ventures
- University research institutions
- Public research institutions
- Medical startups
- Products
-
- Gene Expression Analysis Kit
- Protein Labeling Reagent
- Cell Culture Additive
- Drug Discovery Data Analysis Tool
Medical Formulation Manufacturing
- Overview
- Develops and manufactures medical formulations utilizing transdermal absorption technology.
- Competitiveness
- Differentiated transdermal drug technology
- Customers
-
- Pharmaceutical manufacturers
- Hospitals
- Clinics
- Wholesalers
- Products
-
- Transdermal Absorption Formulations
- Anti-Inflammatory Patches
- Immune Modulators
Technology Licensing & Partnerships
- Overview
- Promotes licensing of proprietary technologies and new technology creation through joint development.
- Competitiveness
- Patented technologies and extensive joint research track record
- Customers
-
- Domestic and international pharmaceutical companies
- Research institutions
- Medical device manufacturers
- Products
-
- Transdermal Penetration Technology License
- Joint Research Services
Bio Formulation Contract Services
- Overview
- Provides contract manufacturing of formulations and reagents along with high-precision quality control.
- Competitiveness
- High-precision analysis and reliable manufacturing system
- Customers
-
- Biopharmaceutical companies
- Medical formulation manufacturers
- Products
-
- Drug Discovery Reagent Contract Manufacturing
- Quality Control Analysis Services
Pharmaceutical Stability Evaluation Services
- Overview
- Scientifically evaluates the storage stability and durability of pharmaceuticals.
- Competitiveness
- Detailed analysis and reporting by specialized technologies
- Customers
-
- Pharmaceutical companies
- Pharmaceutical development institutions
- Products
-
- Formulation Stability Testing
- Storage Condition Verification
Regulatory Approval Support Services
- Overview
- Provides consulting support for regulatory approvals of pharmaceuticals and medical devices.
- Competitiveness
- Extensive approval experience and specialized knowledge
- Customers
-
- Pharmaceutical companies
- Medical device manufacturers
- Products
-
- Application Document Preparation Support
- Evidence Document Preparation
Competitive Advantage
Strengths
- Proprietary transdermal penetration technology
- Flexibility as a drug discovery venture
- High research and development capabilities
- Robust patent portfolio
- Collaboration strength with partner companies
- Specialized pharmaceutical development expertise
- Broad bio formulation technologies
- Sound capital policies
- Diversity of research reagents
- Market adaptability in niche areas
- Increasing recognition in medical settings
- Safety-focused product design
- Clinical development support system
- Sustainable manufacturing processes
- High regulatory compliance capabilities
Competitive Advantages
- Optimization of active ingredient permeation via transdermal technology
- Specialization in R&D for pharmaceuticals targeting rare diseases
- Advanced technology provision in biotech drug discovery reagents
- Risk diversification through diverse product lines
- Differentiation via innovative transdermal formulations
- Difficulty of imitation due to strong patent protection
- Extensive collaboration network with domestic and international medical institutions
- Continuity and efficiency of R&D investments
- Maintenance of strict quality control and safety standards
- Establishment of sustainable manufacturing systems
- Transparency in management and stable capital policies
- Team of experts proficient in pharmaceutical approvals
- Product customization responsive to customer needs
- Securing of highly skilled technical personnel
- Rapid market launch capabilities
Threats
- Strengthened regulations in the pharmaceutical industry
- Intensified competition with major pharmaceutical companies
- Rising costs of pharmaceutical development
- Risk of delays in technological innovation
- Competitor entry due to patent expiration
- Intensified price competition in the market
- Increase in new entrants
- Uncertainty in clinical trial outcomes
- Fluctuations in funding procurement
- Potential impacts from international situations
- Changes in healthcare policies
- Fluctuations in raw material prices
Innovations
2023: New Development of Transdermal Absorption Formulations
- Overview
- Advanced formulation development of analgesics using new transdermal penetration technology, improving efficacy and safety.
- Impact
- Successfully differentiated in the market and expanded product lineup
2024: High-Performance Enhancement of Biotech Drug Discovery Reagents
- Overview
- Launched new products for drug discovery research reagents applying gene editing technology.
- Impact
- Improved customer satisfaction through accelerated research
2022: Launch of Clinical Trial Design Support Services
- Overview
- Newly started consulting business for clinical trial design support targeted at pharmaceutical companies.
- Impact
- Contributed to expansion of customer base
2021: Expansion of Joint Research Partnerships
- Overview
- Entered into multiple drug discovery joint research contracts with domestic and international pharmaceutical companies.
- Impact
- Strengthened technology exchange and market expansion
2020: Introduction of Environmentally Friendly Manufacturing Processes
- Overview
- Adopted sustainable manufacturing methods achieving reduction in hazardous waste.
- Impact
- Successfully reduced environmental burden
Sustainability
- Manufacturing process improvements for reducing environmental impact
- Proper disposal of pharmaceutical waste
- Promotion of ethical research
- Plans for introducing renewable energy
- Active participation in regional medical support activities
- Implementation of in-house environmental awareness training
- Promotion of sustainable product development
- Adoption of resource-saving packaging materials
- Strengthening of safety and health standards
- Regular publication of environmental reports
- Environmental assessment of supply chains
- Institutional development for promoting women's active roles